Lionheart Holdings Files S-1 Registration

TL;DR

Lionheart Holdings just filed an S-1. Looks like they're gearing up for something big.

AI Summary

Lionheart Holdings filed an S-1 registration statement with the SEC on May 28, 2024. The company, incorporated in the Cayman Islands with its principal executive offices in Fort Lauderdale, Florida, is classified under "Blank Checks" (SIC 6770). This filing indicates a step towards a potential public offering or other securities-related transaction.

Why It Matters

This S-1 filing is a preliminary step for Lionheart Holdings to potentially offer securities to the public, signaling a move towards increased transparency and capital raising activities.

Risk Assessment

Risk Level: medium — As an S-1 filing, it represents an early stage of a potential public offering, which inherently carries market and execution risks.

Key Numbers

• 333-279751 — SEC File Number (Identifies the specific SEC registration)
• 24988482 — Film Number (Internal SEC processing number)

Key Players & Entities

• Lionheart Holdings (company) — Registrant
• SEC (company) — Filing recipient
• May 28, 2024 (date) — Filing date
• Cayman Islands (location) — Jurisdiction of incorporation
• Fort Lauderdale, Florida (location) — Principal executive offices
• 6770 (other) — SIC code for Blank Checks

FAQ

Key Financial Figures

• $200,000,000 — ION, DATED MAY 28, 2024 $200,000,000 Lionheart Holdings 20,000,000&#x00a
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordi
• $11.50 — s A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $1.00 — hare at $11.50 per share, at a price of $1.00 per warrant, or $6,000,000 in the aggre
• $6,000,000 — re, at a price of $1.00 per warrant, or $6,000,000 in the aggregate (whether or not the un
• $3,500,000 — rrants at a price of $1.00 per warrant ($3,500,000 in the aggregate) in a private placemen
• $100,000 — d thereon (less taxes payable and up to $100,000 of interest income to pay dissolution e
• $0.20 — x00a0;    Includes $0.20 per unit (excluding any units sold purs
• $4,000,000 — ption to purchase additional units), or $4,000,000 in the aggregate (whether or not the un
• $0.35 — closing of this offering. Also includes $0.35 per unit on units other than those sold
• $0.55 — option to purchase additional units and $0.55 per unit on units sold pursuant to the
• $7,000,000 — option to purchase additional units, or $7,000,000 in the aggregate or up to $8,650,000 in
• $8,650,000 — or $7,000,000 in the aggregate or up to $8,650,000 in the aggregate if the underwriters&#x
• $200.0 — warrants described in this prospectus, $200.0 million, or $230.0 millio
• $230.0 — s prospectus, $200.0 million, or $230.0 million if the underwriters&#x20

Filing Documents

• ea0203414-04.htm (S-1) — 3350KB
• ea020341404ex3-1_lionheart.htm (EX-3.1) — 512KB
• ea020341404ex3-2_lionheart.htm (EX-3.2) — 303KB
• ea020341404ex4-1_lionheart.htm (EX-4.1) — 20KB
• ea020341404ex4-2_lionheart.htm (EX-4.2) — 20KB
• ea020341404ex4-4_lionheart.htm (EX-4.4) — 187KB
• ea020341404ex5-1_lionheart.htm (EX-5.1) — 11KB
• ea020341404ex5-2_lionheart.htm (EX-5.2) — 53KB
• ea020341404ex10-1_lionheart.htm (EX-10.1) — 45KB
• ea020341404ex10-2_lionheart.htm (EX-10.2) — 93KB
• ea020341404ex10-3_lionheart.htm (EX-10.3) — 130KB
• ea020341404ex10-4_lionheart.htm (EX-10.4) — 39KB
• ea020341404ex10-5_lionheart.htm (EX-10.5) — 57KB
• ea020341404ex10-6_lionheart.htm (EX-10.6) — 105KB
• ea020341404ex10-7_lionheart.htm (EX-10.7) — 21KB
• ea020341404ex10-8_lionheart.htm (EX-10.8) — 50KB
• ea020341404ex10-9_lionheart.htm (EX-10.9) — 12KB
• ea020341404ex14-1_lionheart.htm (EX-14.1) — 49KB
• ea020341404ex23-1_lionheart.htm (EX-23.1) — 1KB
• ea020341404ex99-1_lionheart.htm (EX-99.1) — 40KB
• ea020341404ex99-2_lionheart.htm (EX-99.2) — 30KB
• ea020341404ex99-3_lionheart.htm (EX-99.3) — 2KB
• ea020341404ex99-4_lionheart.htm (EX-99.4) — 2KB
• ea020341404ex99-5_lionheart.htm (EX-99.5) — 2KB
• ea020341404ex99-6_lionheart.htm (EX-99.6) — 2KB
• ea020341404ex-fee_lionheart.htm (EX-FILING FEES) — 94KB
• ex3-1_001.jpg (GRAPHIC) — 2KB
• ex3-1_002.jpg (GRAPHIC) — 2KB
• ex5-2_001.jpg (GRAPHIC) — 2KB
• 0001213900-24-046917.txt ( ) — 5240KB

Risk Factors

Risk Factors   41 Cautionary Note Regarding Forward-Looking Statements   87

Use of Proceeds

Use of Proceeds   88 Dividend Policy   91

Dilution

Dilution   92 Capitalization   94 Management’s Discussion and Analysis of Financial Condition and Results of Operations   95 Proposed Business   101 Effecting our Initial Business Combination   109 Management   128 Principal Shareholders   140 Certain Relationships and Related Party Transactions   144

Description of Securities

Description of Securities   147 Taxation   167

Underwriting

Underwriting   178 Legal Matters   188 Experts   188 Where You Can Find Additional Information   188 Index to Financial Statements   F-1 We are responsible for the information contained in this prospectus. We have not, and the underwriters have not, authorized anyone to provide you with information that is different from or inconsistent with that contained in this prospectus. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus. Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. i Table of Contents SUMMARY This summary only highlights the more detailed information appearing elsewhere in this prospectus. As this is a summary, it does not contain all of the information that you should consider in making an investment decision. You should read this entire prospectus carefully, including the information under “Risk Factors” and our financial statements and the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus or the context otherwise requires, references to: •      &#x00a

View Full Filing

View this S-1 filing on SEC EDGAR